Table. 2.
Clinical characteristics of patients with different forms of AF (PAF, PsAF, LSAF) and two groups with AF and AF + IAA.
| Clinical parameters | Patients with different forms of AF | Patients with IAA or AF + IAA | |||
|---|---|---|---|---|---|
| PAF (n = 12) | PsAF (n = 20) | LSAF (n = 23) | AF (n = 37) | AF + IAA (n = 18) | |
| Age, mean ± SD, years | 57.4 ± 8.6 | 57.5 ± 7.4 | 52.0 ± 10.7 | 53.1 ± 9.8 | 59.5 ± 7.1** |
| Male / Female | 8 / 4 | 14 / 6 | 12 / 11 | 25 / 12 | 9 / 9 |
| Left atrial volume, mean ± SD, ml | 133.1 ± 26.3 | 127.8 ± 23.8 | 133.3 ± 25.4 | 131.3 ± 25.0 | 131.5 ± 24.7 |
| Left atrial dimension, mean ± SD, mm | 45.5 ± 5.0 | 48.7 ± 3.5 | 49.3 ± 7.1 | 48.2 ± 6.3 | 48.2 ± 4.2 |
| LV ejection fraction, mean ± SD, % | 65.3 ± 5.8 | 60.2 ± 6.7* | 59.6 ± 8.0* | 60.9 ± 6.7 | 61.4 ± 8.6 |
| Duration of AF, mean ± SD, years (min–max) | 10.0 ± 9.0 (1–27) | 6.2 ± 5.6 (0.5–21) | 6.0 ± 5.0 (1–20) | 6.3 ± 5.9 (1–25) | 8.3 ± 7.3 (0.5–27) |
| Arterial hypertension, % of patients | 41.7 | 30 | 47.8 | 35.1 | 50 |
| Mitral valve regurgitation, degree 2–3, % of patients | 8.3 | 40 | 34.8 | 24.3 | 44.4** |
| Diameter of mitral valve fibrous ring, mean ± SD, mm | 35 ± 3 | 34.6 ± 1.9 | 37.3 ± 3.7*† | 35 ± 3 | 37 ± 4 |
| Tricuspid valve regurgitation, degree 2–3, % of patients | 0 | 15 | 26.1 | 10.8 | 22.2 |
| Diameter of tricuspid valve fibrous ring, mean ± SD, mm | 33.9 ± 2.8 | 35.3 ± 2.6 | 37.7 ± 4.0* | 36 ± 3 | 37 ± 4 |
*Comparison with PAF, Mann–Whitney U Test p < 0.05.
†Comparison with PsAF, Mann–Whitney U Test p < 0.05.
**Comparison AF + IAA group with AF group, Mann–Whitney U Test p < 0.05.